Cassava Sciences's (SAVA) Simufilam Improves Cognition and Behavior in Alzheimer’s Disease in Interim Analysis of Open-label Study

Go back to Cassava Sciences's (SAVA) Simufilam Improves Cognition and Behavior in Alzheimer’s Disease in Interim Analysis of Open-label Study
(NASDAQ: SAVA) Delayed: 38.66 -0.57 (1.45%)
Previous Close $39.23    52 Week High
Open $39.14    52 Week Low
Day High $39.90    P/E N/A 
Day Low $38.49    EPS
Volume 146,348